Fort Worth, Texas Clinical Trials

Adenocarcinoma

Arizona Oncology Associates (Site 244)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Minnesota Oncology Hematology, Site #239

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Oncology Hematology Care (Site 114)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rocky Mountain Cancer Centers - Boulder (Site 191)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Texas Oncology Fort Worth at 12th Avenue

Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Alzheimer's Disease

Univ of North Texas Health Science Center

A Phase 3 clinical study for patients with Alzheimer's Disease

University of North Texas Health Science Center; Fort Worth Patient Care Center

Patients are needed to participate in a clinical research study of Crenezumab and Placebo to evaluate Alzheimer's Disease, Mild Alzheimer's Disease (AD)

Anemia

Investigational Site

A clinical trial to evaluate treatments using FG-4592 and Epoetin Alfa for patients with Anemia of End-stage Renal Disease

Investigational Site

A clinical trial to evaluate treatments using FG-4592 and Epoetin Alfa for patients with Anemia of End-stage Renal Disease

Investigational Site

A clinical trial to evaluate treatments using FG-4592 and Epoetin Alfa for patients with Anemia of End-stage Renal Disease

Investigational Site

A clinical trial to evaluate treatments using FG-4592 and Epoetin Alfa for patients with Anemia of End-stage Renal Disease

Investigational Site

A clinical trial to evaluate treatments using FG-4592 and Epoetin Alfa for patients with Anemia of End-stage Renal Disease

View More »

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Asthma

Research Site

A clinical research study for asthmatics 12 years and over.

Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Asthma

Novartis Investigative Site

Patients are needed to participate in a clinical research study of QAW039 and Placebo to evaluate Asthma

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

North Texas Clinical Trials

T-Force Green, a clinical research study for children and adolescents with Tourette syndrome.

Bladder Cancer

Center for Cancer and Blood Disorders

A clinical trial seeking patients for a research study for the treatment of Urothelial Carcinoma, Bladder Cancer or Transitional Cell Carcinoma

Blurred Vision

Retina Consultants, PA

Patients are needed to participate in a clinical research study of Diagnostic procedures to evaluate Anterior Ischemic Optic Neuropathy

Brain Cancer

Cook Children's Medical Center

Patients are needed to participate in a clinical research study for the treatment of Medulloblastoma

Breast Cancer

Oncology Hematology Consultants PA

Study of Glembatumumab Vedotin (CDX-011) in Patients With Advanced GPNMB Over-expressing Triple-Negative Breast Cancer. (METRIC)

View More »

Research Site

A clinical trial to evaluate treatments using BMN 673 and Physician's-Choice for patients with Breast Neoplasms, BRCA 1 Gene Mutation or BRCA 2 Gene Mutation

Research Site

A clinical research study of Eribulin Mesylate and Pembrolizumab for the treatment of Breast Cancer, Triple-Negative Breast Cancer (mTNBC)

Center for Cancer and Blood Disorders

A clinical trial seeking patients for a research study for the treatment of Metastatic Breast Cancer

Center for Cancer and Blood Disorders (SCRI)

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

Center for Cancer and Blood Disorders SC-2

A clinical trial seeking patients for a research study for the treatment of Breast Cancer, Advance Breast Cancer

Investigator Site - Fort Worth

A study of NKTR-102 vs Treatment of Physician’s Choice in patients with metastatic breast cancer with stable brain metastases.

Oncology Hematology Consultants PA Updated

A clinical trial to evaluate treatments using CDX-011 and Capecitabine for patients with Metastatic GPNMB Over-expressing Triple Negative Breast Cancer

The Center for Cancer and Blood Disorders

A clinical research study of paclitaxel, Reparixin and placebo for the treatment of Metastatic Breast Cancer, Triple-Negative Breast Cancer

The Center for Cancer and Blood Disorders

A clinical trial to evaluate treatments using Abemaciclib, Tamoxifen and Prophylactic Loperamide for patients with Metastatic Breast Cancer

The Center for Cancer and Blood Disorders Updated

A clinical trial to evaluate treatments using Trilaciclib, Gemcitabine and Carboplatin for patients with Triple-Negative Breast Neoplasms, Breast Neoplasm, Breast Cancer or Triple-Negative Breast Cancer

The Center for Cancer and Blood Disorders - Fort Worth Updated

A Phase 2 clinical study for patients with Metastatic Breast Cancer

The Center for Cancer and Blood Disorders (Fort Worth)

A clinical research study of VT-464; given orally once daily in 28 day cycles, Advanced Breast Cancer

US Oncology

A clinical research study of VT-464; given orally once daily in 28 day cycles, Advanced Breast Cancer

Breast Cancer - HER2 Positive

Center for Cancer and Blood Disorders (SCRI)

Patients are needed to participate in a clinical research study of ONT-380, Capecitabine, Trastuzumab and Placebo to evaluate HER2 Positive Breast Cancer

The Center for Cancer and Blood Disorders

A Phase 2 clinical study for patients with Hormone Receptor Positive Tumor or HER-2 Positive Breast Cancer

The Center for Cancer and Blood Disorders Updated

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Cataracts

Research Site

Patients are needed to participate in a clinical research study of Hydrus Aqueous Implant and Cataract surgery to evaluate Primary Open Angle Glaucoma

Research Site

Patients are needed to participate in a clinical research study evaluating iStent supra and Cataract surgery for the treatment of Primary Open-angle Glaucoma

Contact Alcon Call Center for Trial Locations Updated

Patients are needed to participate in a clinical research study evaluating Manifest refraction, ACRYSOF® IQ Monofocal IOL Model SN60WF and Topcon® KR-1W Wave-Front Analyzer for the treatment of Cataract

Chronic Lymphocytic Leukemia

Center for Cancer Blood Disorders

Clinical trial for People with Chronic Lymphocytic Leukemia (CLL)

View More »

JPS Center for Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

TG Therapeutics Investigational Trial Site

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

Clostridium Difficile-Associated Diarrhea

Investigational Site 119

A clinical trial to evaluate treatments using C. difficile Toxoid Vaccine and Placebo: 0.9% normal saline for patients with Clostridium Difficile Infection

Site US10038

A Phase 3 clinical study for patients with Clostridium Difficile-associated Diarrhea (CDAD)

Ventavia Research Group, LLC

Patients are needed to participate in a clinical research study evaluating Clostridium difficile vaccine and Placebo for the treatment of Clostridium Difficile Infection

Colorectal Cancer

Texas Oncology - Fort Worth

A clinical research study for the treatment of Colorectal Cancer

COPD (Chronic Obstructive Pulmonary Disease)

Pearl Investigative Site

A clinical trial seeking patients for a research study for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site Updated

A clinical research study of BGF MDI 320/14.4/9.6 μg, GFF MDI 14.4/9.6 μg, BGF MDI 160/14.4/9.6 μg and BFF MDI 320/9.6 μg for the treatment of COPD

Coronary Artery Disease

Harrison Methodist

Patients are needed to participate in a clinical research study evaluating Absorb BVS and XIENCE for the treatment of Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease or Coronary Stenosis

Crohn's Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Cook Childrens Medical Center

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Cystic Fibrosis

Research Site

Patients are needed to participate in a clinical research study of VX-371, Saline, Placebo and Orkambi to evaluate Cystic Fibrosis

Research Site

A clinical trial to evaluate treatments for patients with Cystic Fibrosis

Site Reference ID/Investigator# 78949

A clinical trial to evaluate treatments for patients with Fibrosing Colonopathy in Patients With Cystic Fibrosis

Dementia

Univ of North Texas Health Science Center

A Phase 3 clinical study for patients with Alzheimer's Disease

Depression

North Texas Clinical Trials

Patients are needed to participate in a clinical research study of Rapastinel and Placebo to evaluate Depressive Disorder, Major

North Texas Clinical Trials

Patients are needed to participate in a clinical research study of Rapastinel to evaluate Depressive Disorder, Major

North Texas Clinical Trials

Patients are needed to participate in a clinical research study of Rapastinel and Placebo-matching Rapastinel to evaluate Depressive Disorder, Major

Dermatitis, Atopic

Advanced Allergy Associates

Patients are needed to participate in a clinical research study of Dupilumab, Auto-injector Device and Prefilled syringe to evaluate Atopic Disorders or Eczema, Atopic

Diabetes Mellitus, Type 2

Research Site

A Phase 3 clinical study of Ertugliflozin for patients with Type 2 Diabetes Mellitus with Stage 3 Chronic Kidney Disease who have inadequate glycemic control on metformin

Research Site

Does type 2 diabetes run in your family? Then sit up and take notice

View More »

Call for Information (Investigational Site 0456)

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Investigational Site Number 8401005

A clinical research study of Sotagliflozin (SAR439954) and Placebo for the treatment of Type 2 Diabetes Mellitus

Investigational Site Number 8402010

Patients are needed to participate in a clinical research study of Sotagliflozin (SAR439954), Placebo and Metformin to evaluate Type 2 Diabetes Mellitus

Investigational Site Number 840307

Patients are needed to participate in a clinical research study evaluating Insulin Glargine (U300), Insulin Glargine (U100) and Insulin Detemir (Levemir) for the treatment of Diabetes Mellitus, Type 2 (Achieve Control Real Life Study Program)

Novo Nordisk Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Diabetes or Diabetes Mellitus, Type 2

Novo Nordisk Investigational Site

Patients are needed to participate in a clinical research study to evaluate Diabetes or Diabetes Mellitus, Type 2

Diabetic Foot Ulcers

Acclaim Bone & Joint Updated

A clinical trial to evaluate treatments using PICO - Negative Pressure Wound Therapy (NPWT) and ActiV.A.C.® for patients with Venous Leg Ulcers or Diabetic Foot Ulcers

Diabetic Retinopathy

Research Site

A clinical trial seeking patients for a research study for the treatment of Nonproliferative Diabetic Retinopathy (NPDR)

Digestive System Neoplasms

Texas Oncology - Fort Worth

A clinical research study for the treatment of Colorectal Cancer

Epilepsy

Cook Childrens Medical Center

A clinical trial seeking patients for a research study for the treatment of Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)

Cook Children's Medical Center

Patients are needed to participate in a clinical research study of ZX008 (Fenfluramine Hydrochloride (HCL)) and Matching Placebo to evaluate Dravet Syndrome or Seizure Disorder

Erectile Dysfunction

Retina Consultants, PA

Patients are needed to participate in a clinical research study of Diagnostic procedures to evaluate Anterior Ischemic Optic Neuropathy

Fallopian Tube Cancer

SCRI Center for Cancer and Blood Disorders

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Texas Oncology

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Follicular Lymphoma

Investigational Products Center (I PC) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Investigational Products Center (IPC) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Investigational Products Center (IPC), (drug shipment only) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Glaucoma

Research Site

Patients are needed to participate in a clinical research study evaluating iStent supra and Cataract surgery for the treatment of Primary Open-angle Glaucoma

Research Site

Patients are needed to participate in a clinical research study of Hydrus Aqueous Implant and Cataract surgery to evaluate Primary Open Angle Glaucoma

Ophthalmology Associates

A clinical trial to evaluate treatments using Glaucoma Surgery and InnFocus MicroShunt for patients with Primary Open Angle Glaucoma

Ophthalmology Associates Updated

A clinical research study of VISCO360 ab interno canaloplasty surgery and Selective Laser Trabeculoplasty (SLT) for the treatment of Open-Angle Glaucoma

Heart Failure

Research Site

A clinical study for patients with Heart Failure

Research Site

A clinical research study for the treatment of Heart Failure

Research Site

Patients are needed to participate in a clinical research study evaluating Medtronic Cardiac Resynchronization Therapy (CRT-D) for the treatment of Heart Failure

Hemodialysis

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Research Center

Patients are needed to participate in a clinical research study evaluating Epoetin Alfa and FG-4592 for the treatment of Anemia, Iron Deficiency

Hemorrhage

Portola Investigational Site

A Phase 3 clinical study for Bleeding patients

Hepatitis

Research Site Updated

A clinical research study of TAF and Placebo for the treatment of Chronic Hepatitis B

Hepatitis B

Research Site Updated

A clinical research study of TAF and Placebo for the treatment of Chronic Hepatitis B

High Blood Pressure (Hypertension)

Cook Children's Medical Center

A clinical research study of IV Remodulin and Placebo for the treatment of Persistent Pulmonary Hypertension of the Newborn

Hypogonadism

Mereo Research Site

A clinical research study of BGS649 and Placebo for the treatment of Hypogonadotropic Hypogonadism

Inflammatory Bowel Disease

Research Site

A clinical research study of Rifaximin Delayed Release (DR) and Placebo for the treatment of Crohn's Disease

Cook Childrens Medical Center

A Phase 4 clinical study for patients with Inflammatory Bowel Disease

Cook Childrens Medical Center

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Influenza

Research Site

A clinical research study of Fluzone® Quadrivalent Influenza Vaccine, No Preservative for the treatment of Influenza

Insomnia

Research Site

A clinical trial to evaluate treatments using lemborexant and Placebo for patients with Insomnia Disorder

Kidney Disease

Research Site

A Phase 3 clinical study of Ertugliflozin for patients with Type 2 Diabetes Mellitus with Stage 3 Chronic Kidney Disease who have inadequate glycemic control on metformin

View More »

Investigational Product Center (IPC) Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Investigational Products Center (IPC) Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Investigational Products Center (IPC) Drug Shipment Only Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Investigational Products Center (lPC) Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Research Site

A Phase 3 clinical study for patients with Chronic Kidney Disease

Research Site

A Phase 3 clinical study for patients with Chronic Kidney Disease

Research Site

A Phase 3 clinical study for patients with Chronic Kidney Disease

Site Reference ID/Investigator# 105159

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Kidney Transplantation

Baylor All Saints Medical Center

A clinical trial seeking patients for a research study for the treatment of Kidney Transplantation or Focal Segmental Glomerulosclerosis (FSGS)

Leukemia

Cook Children's Medical Center

A clinical trial to evaluate treatments for patients with Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma or Peripheral T-cell Lymphoma

Cook Children's Medical Center

Patients are needed to participate in a clinical research study evaluating Selinexor, Fludarabine, Cytarabine and methotrexate/hydrocortisone/cytarabine for the treatment of Acute Myeloid Leukemia (AML)

JPS Center for Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

TG Therapeutics Investigational Trial Site

Patients are needed to participate in a clinical research study evaluating Obinutuzumab, Ublituximab, TGR-1202 and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia

Liver Cancer

Contact Incyte Corporation Call Center at 1.855.463.3463

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy

Research Center New

A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Translocations Who Failed Previous Therapy

Lung Cancer

Arizona Oncology Associates (Site 244)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Minnesota Oncology Hematology, Site #239

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Oncology Hematology Care (Site 114)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rocky Mountain Cancer Centers - Boulder (Site 191)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Texas Oncology-Fort Worth 12th Ave

A clinical trial to evaluate treatments using Nivolumab in combination with Ipilimumab for patients with Lung Cancer

View More »

Texas Oncology-Plano East

A clinical trial to evaluate treatments using Nivolumab in combination with Ipilimumab for patients with Lung Cancer

Lung Disease

Texas Pul & Crit Care Conslt Updated

A clinical research study of Nintedanib and Placebo for the treatment of Lung Diseases, Interstitial

Lymphoma

Call for Information (Investigational Site 0069)

A clinical trial seeking patients for a research study for the treatment of Melanoma, Lymphoma or Solid Tumor

Call for Information (Investigational Site 8006)

A Phase 3 clinical study for patients with Hodgkin Lymphoma

Cook Children's Medical Center

A clinical trial to evaluate treatments for patients with Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma or Peripheral T-cell Lymphoma

Investigational Products Center (I PC) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Investigational Products Center (IPC) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

View More »

Investigational Products Center (IPC), (drug shipment only) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Texas Oncology - Fort Worth 12th Avenue

A Phase 2 clinical study for patients with Hodgkin Disease

Macular Degeneration

Cornea Consultants of Texas

Patients are needed to participate in a clinical research study of Implantable Miniature Telescope (IMT) to evaluate Age-related Macular Degeneration

Malignant Melanoma

Texas Oncology

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Melanoma

Call for Information (Investigational Site 0069)

A clinical trial seeking patients for a research study for the treatment of Melanoma, Lymphoma or Solid Tumor

Texas Oncology

A Phase 1/Phase 2 clinical study for patients using Rovalpituzumab tesirine

Meningitis

GSK Investigational Site

A clinical trial seeking patients for a research study for the treatment of Infections, Meningococcal

Myocardial Ischemia

Harrison Methodist

Patients are needed to participate in a clinical research study evaluating Absorb BVS and XIENCE for the treatment of Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease or Coronary Stenosis

Neoplasm Metastasis

Investigator Site - Fort Worth

A study of NKTR-102 vs Treatment of Physician’s Choice in patients with metastatic breast cancer with stable brain metastases.

The Center for Cancer and Blood Disorders Updated

A clinical trial to evaluate treatments for patients with HER-2 Positive Breast Cancer or Metastatic Neoplasm

Neoplasms

Center for Cancer and Blood Disorders SC-2

A clinical trial seeking patients for a research study for the treatment of Breast Cancer, Advance Breast Cancer

Texas Oncology - Fort Worth

A clinical research study for the treatment of Colorectal Cancer

Texas Oncology - Fort Worth 12th Ave

Patients are needed to participate in a clinical research study evaluating BBI608 and BBI503 for the treatment of Cancer or Advanced Solid Tumors

Texas Oncology, P.A. - Fort Worth

Patients are needed to participate in a clinical research study evaluating MSB0011359C (M7824) for the treatment of Solid Tumors, Metastatic or Locally Advanced Solid Tumors

Texas Oncology-Fort Worth

A clinical trial seeking patients for a research study for the treatment of Neoplasms or Cancer

View More »

Texas Oncology-Southwest Fort Worth

A clinical trial seeking patients for a research study for the treatment of Neoplasms or Cancer

The Center for Cancer and Blood Disorders Updated

A clinical trial to evaluate treatments using Trilaciclib, Gemcitabine and Carboplatin for patients with Triple-Negative Breast Neoplasms, Breast Neoplasm, Breast Cancer or Triple-Negative Breast Cancer

The Center for Cancer and Blood Disorders - Fort Worth

A clinical trial seeking patients for a research study for the treatment of Neoplasms

Nephropathy

Site Reference ID/Investigator# 105159

A clinical trial to evaluate treatments using Atrasentan and Placebo for patients with Diabetic Nephropathy

Neuroblastoma

Cook Children's Health Care System

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin™ in High-Risk Neuroblastoma Patients

Non-Hodgkin's Lymphoma

Cook Children's Medical Center

A clinical trial to evaluate treatments for patients with Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma or Peripheral T-cell Lymphoma

Investigational Products Center (I PC) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Investigational Products Center (IPC) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Investigational Products Center (IPC), (drug shipment only) Updated

A Phase 3 clinical study for patients with Follicular Lymphoma

Non-Small Cell Lung Cancer

Arizona Oncology Associates (Site 244)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Center for Cancer and Blood Disorders Updated

Patients are needed to participate in a clinical research study to evaluate Squamous Cell Carcinoma, Non-Small-Cell Lung

Investigational Products Ctr

Patients are needed to participate in a clinical research study for the treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate 370)

Minnesota Oncology Hematology, Site #239

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Oncology Hematology Care (Site 114)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

View More »

Rocky Mountain Cancer Centers - Boulder (Site 191)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Texas Oncology

Patients are needed to participate in a clinical research study for the treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate 370)

The Center For Cancer And Blood Disorders

Patients are needed to participate in a clinical research study for the treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (CheckMate 370)

Obsessive-Compulsive Disorder

North Texas Clinical Trials

T-Force Green, a clinical research study for children and adolescents with Tourette syndrome.

Ocular Hypertension

Contact Alcon Call Center for Trial Locations Updated

A clinical trial seeking patients for a research study for the treatment of Open-angle Glaucoma or Ocular Hypertension

Contact Alcon Call Center for Trial Locations

A Phase 4 clinical study for patients with Open-Angle Glaucoma or Ocular Hypertension

Ovarian Cancer

SCRI Center for Cancer and Blood Disorders

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Texas Oncology

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

View More »

Research Site

Patients are needed to participate in a clinical research study of Niraparib and Placebo to evaluate Ovarian Cancer

Research Site

A clinical trial to evaluate treatments using Niraparib for patients with Ovarian Cancer

Investigational Products Center Updated

A Phase 3 clinical study for patients with Ovarian Cancer

Investigational Products Center Updated

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Investigational Products Center (IPC) Updated

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Texas Oncology - Fort Worth 12th Ave Updated

A Phase 3 clinical study for patients with Ovarian Cancer, Platinum Resistant/Refractory Ovarian Cancer

Texas Oncology-Fort Worth /ID# 143811

A Phase 3 clinical study for patients with Ovarian Cancer or Ovarian Neoplasm, Fallopian Tube, or Primary Peritoneal Cancer

Texas Oncology-Fort Worth 12th Ave. Updated

A Phase 3 clinical study for patients with Ovarian Cancer

Peritoneal Cancer

SCRI Center for Cancer and Blood Disorders

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Texas Oncology

A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Women With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received at Least Three Previous Chemotherapy Regimens

Renal Cell Cancer

Investigational Product Center (IPC) Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Investigational Products Center (IPC) Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Investigational Products Center (IPC) Drug Shipment Only Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Investigational Products Center (lPC) Updated

Patients are needed to participate in a clinical research study of Avelumab (MSB0010718C), Axitinib (AG-013736) and Sunitinib to evaluate Renal Cell Cancer

Renal Cell Carcinoma

Texas Oncology-Fort Worth 12th Ave Updated

Patients are needed to participate in a clinical research study evaluating Nivolumab and Ipilimumab for the treatment of Renal Cell Carcinoma

Sarcoma

Novartis Investigative Site

A clinical research study of Pazopanib GW786034 for the treatment of Solid Tumours (COG)

Schizophrenia and Schizoaffective Disorders

John Peter Smith

A clinical trial seeking patients for a research study for the treatment of Schizophrenia (FIRST)

US1443

A clinical research study of Risperidone, Olanzapine and Lu AF35700 for the treatment of Schizophrenia

Sickle Cell Disease

Cook Children's Hematology and Oncology Center

A clinical trial seeking patients for a research study for the treatment of Sickle Cell Anemia

Cook Children's Medical Center

A clinical trial seeking patients for a research study for the treatment of Sickle Cell Anemia

Small Cell Lung Cancer

Texas Oncology

Patients are needed to participate in a clinical research study of Rovalpituzumab Tesirine, Cisplatin and Etoposide to evaluate Small Cell Lung Cancer

Soft Tissue Infections

Call for Information (Investigational Site 0106)

A clinical trial to evaluate treatments using Tedizolid Phophate 200 mg, IV to oral for 6 days and Antibiotic comparator for patients with Skin Diseases, Infectious or Skin Diseases, Bacterial Skin Diseases (cSSTI)

John Peter Smith Health Network

Patients are needed to participate in a clinical research study of AB103 0.5 mg/kg and NaCl 0.9% to evaluate Necrotizing Soft Tissue Infections, Necrotizing Fasciitis or Fournier's Gangrene

Solid Tumors

Research Site

A clinical research study of Lenvatinib and Pembrolizumab for the treatment of Tumors

Texas Oncology, P.A. - Fort Worth

Patients are needed to participate in a clinical research study evaluating MSB0011359C (M7824) for the treatment of Solid Tumors, Metastatic or Locally Advanced Solid Tumors

Squamous Cell Carcinoma

Arizona Oncology Associates (Site 244)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Minnesota Oncology Hematology, Site #239

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Oncology Hematology Care (Site 114)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Rocky Mountain Cancer Centers - Boulder (Site 191)

A clinical research study of Brigatinib and Xalkori (crizotinib) for the treatment of Non-small Cell Lung Cancer, Lung Cancer, Advanced Malignancies or Carcinoma

Stem Cell Transplant

Cook Childrens Hospital

A clinical research study of Defibrotide and Best Supportive Care for the treatment of Veno-occlusive Disease

Thromboembolism

Research Site

A Phase 3 clinical study for patients with Venous Thromboembolism

Tourette's Syndrome

North Texas Clinical Trials

T-Force Green, a clinical research study for children and adolescents with Tourette syndrome.

Ulcerative Colitis

Cook Childrens Medical Center

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Receptos Study Site 206

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis, Moderate to Severe

Ventavia Research Group, LLC

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis, Moderate to Severe

Ulcers

Acclaim Bone & Joint Updated

A clinical trial to evaluate treatments using PICO - Negative Pressure Wound Therapy (NPWT) and ActiV.A.C.® for patients with Venous Leg Ulcers or Diabetic Foot Ulcers

Cook Childrens Medical Center

A Phase 4 clinical study for patients with Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis or Inflammatory Bowel Diseases

Receptos Study Site 206

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis, Moderate to Severe

Ventavia Research Group, LLC

A clinical trial seeking patients for a research study for the treatment of Ulcerative Colitis, Moderate to Severe

Urticaria

Novartis Investigative Site

A clinical trial to evaluate treatments using QGE031 for patients with Chronic Spontaneous Urticaria

Uterine Fibroids

Baylor Scott & White Research Institute

Sonography Guided Transcervical Ablation of Uterine Fibroids (SONATA)

Venous Leg Ulcers

Acclaim Bone & Joint Updated

A clinical trial to evaluate treatments using PICO - Negative Pressure Wound Therapy (NPWT) and ActiV.A.C.® for patients with Venous Leg Ulcers or Diabetic Foot Ulcers

Venous Thromboembolism

Research Site

A Phase 3 clinical study for patients with Venous Thromboembolism

Vision Loss

Retina Consultants, PA

Patients are needed to participate in a clinical research study of Diagnostic procedures to evaluate Anterior Ischemic Optic Neuropathy